These MCTs and melanoma can evade the immune system by expressing high levels of immune checkpoint molecules such as PD-L1, PD-L2, and PD-1, which inhibit T-lymphocyte function and allow tumor cells to escape immune detection and destruction. This evidence concerns the gene CD274 and neoplasm.